Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Return on Equity (2019 - 2023)

Avai Bio's Return on Equity history spans 4 years, with the latest figure at 2.68% for Q4 2023.

  • For Q4 2023, Return on Equity rose 402.0% year-over-year to 2.68%; the TTM value through Dec 2023 reached 2.68%, up 402.0%, while the annual FY2020 figure was 1.59%, N/A changed from the prior year.
  • Return on Equity for Q4 2023 was 2.68% at Avai Bio, up from 1.28% in the prior quarter.
  • Across five years, Return on Equity topped out at 2.88% in Q3 2020 and bottomed at 4.23% in Q4 2020.
  • The 4-year median for Return on Equity is 0.97% (2023), against an average of 0.39%.
  • The largest annual shift saw Return on Equity crashed -71bps in 2020 before it surged 402bps in 2023.
  • A 4-year view of Return on Equity shows it stood at 1.11% in 2019, then plummeted by -482bps to 4.23% in 2020, then skyrocketed by 68bps to 1.34% in 2022, then soared by 301bps to 2.68% in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Return on Equity are 2.68% (Q4 2023), 1.28% (Q3 2023), and 0.97% (Q2 2023).